Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion evidence source_evidence_literature NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion SIO_000772 21205929 NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion wasDerivedFrom befree-2016 NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion wasGeneratedBy ECO_0000203 NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- befree-2016 importedOn "2016-02-19" NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.